139 related articles for article (PubMed ID: 9071154)
21. A dose response study of oxitropium bromide in chronic bronchitis.
Peel ET; Anderson G
Thorax; 1984 Jun; 39(6):453-6. PubMed ID: 6463915
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial).
Bellia V; Foresi A; Bianco S; Grassi V; Olivieri D; Bensi G; Volonté M;
Respir Med; 2002 Nov; 96(11):881-9. PubMed ID: 12418585
[TBL] [Abstract][Full Text] [Related]
23. [Long-acting m-cholinolytic thiotropium bromide (spiriva) in therapy of patients with chronic obstructive pulmonary disease (stage 3)].
Shmelev EI; Khmel'kova MA
Ter Arkh; 2005; 77(12):74-6. PubMed ID: 16514826
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of inhaled anticholinergic drug on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary disease.
Teramoto S; Matsuse T; Sudo E; Ohga E; Katayama H; Suzuki M; Ouchi Y; Fukuchi Y
Intern Med; 1996 Oct; 35(10):772-8. PubMed ID: 8933184
[TBL] [Abstract][Full Text] [Related]
25. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652
[TBL] [Abstract][Full Text] [Related]
26. [The effect of bronchodilators in aerosol form on pulmonary function in patients with pulmonary emphysema].
Bosnjak-Petrović V; Radovanović S
Plucne Bolesti; 1989; 41(1-2):72-4. PubMed ID: 2798578
[TBL] [Abstract][Full Text] [Related]
27. [Physical exercise tolerance in chronic obstructive emphysematous bronchitis and coronary heart disease under antiobstructive therapy].
Hürter T; Ochs JG; Schmitz E; Hartmann M; Alex C; Sigmund M; Hanrath P
Dtsch Med Wochenschr; 1992 Oct; 117(43):1623-9. PubMed ID: 1425260
[TBL] [Abstract][Full Text] [Related]
28. [Effect of theophylline on disturbances of ventilation and of gas exchange during exercise in patients with pulmonary emphysema].
Senju S; Toyoshima H; Ikeda A; Aritomi T; Watanabe K; Ishibashi M; Yoshida M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1204-11. PubMed ID: 8583711
[TBL] [Abstract][Full Text] [Related]
29. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C
Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
[TBL] [Abstract][Full Text] [Related]
30. Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects.
Fujimura M; Kamio Y; Matsuda T; Hashimoto T
Clin Auton Res; 1993 Feb; 3(1):31-5. PubMed ID: 8477178
[TBL] [Abstract][Full Text] [Related]
31. [The effect of inhaled anticholinergic drug on dyspnea and on the physiologic function of respiratory system in patients with chronic obstructive pulmonary disease].
Teramoto S; Suzuki M; Matsuse T; Ohga E; Katayama H; Fukuchi Y; Ouchi Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1209-14. PubMed ID: 9493448
[TBL] [Abstract][Full Text] [Related]
32. [Comparative efficacy of choline antagonists in chronic obstructive lung disease].
Pavlishchuk SA; Bolotova EV
Probl Tuberk Bolezn Legk; 2005; (7):37-9; discussion 39-40. PubMed ID: 16130427
[TBL] [Abstract][Full Text] [Related]
33. [Effects of pulmonary rehabilitation on vital capacity in patients with chronic pulmonary emphysema].
Inoue M; Ohtsu I; Tomioka S; Hagiya M; Sumi M; Aoki H; Homma T; Hasegawa S
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1182-8. PubMed ID: 8976071
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease.
Koyama H; Nishimura K; Ikeda A; Izumi T
Chest; 1993 Dec; 104(6):1743-7. PubMed ID: 8252955
[TBL] [Abstract][Full Text] [Related]
35. Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema.
Horiguchi T; Tachikawa S; Kondo R; Shiga M; Hirose M; Fukumoto K
Arzneimittelforschung; 2002; 52(10):764-8. PubMed ID: 12442639
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
37. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
Cooper CB
Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
[TBL] [Abstract][Full Text] [Related]
38. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
[TBL] [Abstract][Full Text] [Related]
39. [Tracheal smooth muscle dilation effect by anticholinergic agent in chronic pulmonary emphysema].
Shindo T; Shioya T; Kagaya M; Itaha M; Sano M; Ito N; Kashima M; Sasaki M; Miura M
J Smooth Muscle Res; 1995 Dec; 31(6):480-2. PubMed ID: 8867979
[No Abstract] [Full Text] [Related]
40. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.
Baldi S; Ruffini E; Harari S; Roviaro GC; Nosotti M; Bellaviti N; Venuta F; Diso D; Rea F; Schiraldi C; Durigato A; Pavanello M; Carretta A; Zannini P
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1616-22. PubMed ID: 16308007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
